Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of a Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling

NCT06748950 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06748950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06748950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of a Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2025
Completion date
July 31, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar and related disorders, bipolar disorder, ketogenic dieting, ketosis, major depression severe, major depressive disorder, metabolic disease, metabolic syndrome, schizophrenia, schizophrenia and related disorders